Eledon Pharmaceuticals (ELDN) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 127.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.79% |
| Dec 31, 2025 | -26.05% |
| Sep 30, 2025 | 116.53% |
| Jun 30, 2025 | -14.55% |
| Mar 31, 2025 | -51.97% |
| Dec 31, 2024 | -37.66% |
| Sep 30, 2024 | -58.44% |
| Jun 30, 2024 | 41.45% |
| Mar 31, 2024 | 67.07% |
| Dec 31, 2023 | -20.56% |
| Sep 30, 2023 | 80.71% |
| Jun 30, 2023 | 101.22% |
| Mar 31, 2023 | 2.36% |
| Dec 31, 2022 | 85.82% |
| Sep 30, 2022 | -5.25% |
| Jun 30, 2022 | -12.44% |
| Mar 31, 2022 | 77.53% |
| Dec 31, 2021 | 87.00% |
| Sep 30, 2021 | 79.27% |
| Jun 30, 2021 | -21.73% |
| Mar 31, 2021 | -25.80% |
| Dec 31, 2020 | -18.99% |
| Sep 30, 2020 | -19.22% |
| Jun 30, 2020 | -27.06% |
| Mar 31, 2020 | -28.92% |
| Dec 31, 2019 | 98.91% |
| Sep 30, 2019 | -16.58% |
| Jun 30, 2019 | 4.07% |
| Mar 31, 2019 | -1.42% |
| Dec 31, 2018 | -18.57% |
| Sep 30, 2018 | -21.05% |
| Jun 30, 2018 | -31.26% |
| Mar 31, 2018 | -37.92% |
| Dec 31, 2017 | -45.22% |
| Sep 30, 2017 | -43.36% |
| Jun 30, 2017 | 2.21% |
| Mar 31, 2017 | -3.34% |
| Dec 31, 2016 | -67.23% |
| Sep 30, 2016 | -6.94% |